LENZILUMAB OUTCOMES ACCORDING TO RACE OF COVID-19 PARTICIPANTS IN THE LIVE-AIR PHASE 3 TRIAL

Vincent C. Marconi, Adrian Kilcoyne, Franklin Cerasoli, Christopher Polk, Meghan Lewis, Charles D. Burger, Edward Jordan, Cameron Durrant, Dale Chappell, Zelalem Temesgen
doi: https://doi.org/10.1101/2022.08.18.22278867

Article usage

Article usage: August 2022 to December 2024

AbstractFullPdf
Aug 20227161097
Sep 2022107719
Oct 202266010
Nov 20224409
Dec 20224307
Jan 20231904
Feb 20232319
Mar 20233224
Apr 20232514
May 20231414
Jun 2023843
Jul 2023611
Aug 202321105
Sep 20231042
Oct 20233334
Nov 20231740
Dec 2023801
Jan 2024101
Feb 20241406
Mar 20241672
Apr 20241144
May 2024901
Jun 20241104
Jul 2024946
Aug 202421910
Sep 20242264
Oct 2024781
Nov 202410010
Dec 20241002
Back to top
Posted August 21, 2022.
Download PDF
Data/Code
Email
LENZILUMAB OUTCOMES ACCORDING TO RACE OF COVID-19 PARTICIPANTS IN THE LIVE-AIR PHASE 3 TRIAL
Vincent C. Marconi, Adrian Kilcoyne, Franklin Cerasoli, Christopher Polk, Meghan Lewis, Charles D. Burger, Edward Jordan, Cameron Durrant, Dale Chappell, Zelalem Temesgen
medRxiv 2022.08.18.22278867; doi: https://doi.org/10.1101/2022.08.18.22278867
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area